SCHEMBL4369691

SCHEMBL4369691

Cc1cc(N(c2ccccc2)c2ccccc2)c2ccccc2c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 5/20 0.52
CYP2A6 P11509 2/20 0.52
APAF1 O14727 1/20 0.39
CASP3 P42574 1/20 0.39
CASP6 P55212 1/20 0.39
SENP8 Q96LD8 1/20 0.39
SENP7 Q9BQF6 1/20 0.39
SENP6 Q9GZR1 1/20 0.39
SIGMAR1 Q99720 5/20 0.38
TDP1 Q9NUW8 1/20 0.38
ALDH1A1 P00352 4/20 0.34
HSD17B10 Q99714 3/20 0.34
HIF1A Q16665 1/20 0.34
CYP1B1 Q16678 1/20 0.34
HPGD P15428 2/20 0.34
KDM4E B2RXH2 2/20 0.34
GAA P10253 1/20 0.34
APP P05067 1/20 0.33
MEN1 O00255 1/20 0.33
GLA P06280 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10022988 0.93 CYP1A2 (0.46) CYP1A2CYP2A6APAF1CASP3CASP6
SCHEMBL10592589 0.85 CYP1A2 (0.41) CYP1A2CYP2A6SIGMAR1TDP1APP
SCHEMBL29906511 0.82 CYP1A2 (0.39) CYP1A2CYP2A6APAF1CASP3CASP6
SCHEMBL24797442 0.82 CYP1A2 (0.39) CYP1A2CYP2A6APAF1CASP3CASP6
SCHEMBL27101518 0.82 CYP1A2 (0.52) CYP1A2CYP2A6APAF1CASP3CASP6
SCHEMBL9175156 0.82 CYP1A2 (0.47) CYP1A2CYP2A6APAF1CASP3CASP6
SCHEMBL24153839 0.81 ALDH1A1 (0.39) CYP1A2CYP2A6APAF1CASP3CASP6
SCHEMBL9164378 0.81 CYP1A2 (0.50) CYP1A2CYP2A6SIGMAR1TDP1ALDH1A1
SCHEMBL17636107 0.81 SIGMAR1 (0.45) CYP1A2CYP2A6SIGMAR1ALDH1A1CYP2C19
SCHEMBL10046635 0.81 SIGMAR1 (0.45) CYP1A2CYP2A6SIGMAR1ALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8481785-B2 Materials for N-doping the electron-transporting layers in organic electronic components OSRAM OPTO SEMICONDUCTORS GMBH (DE) 2013-07-09 US disclosed
EP-1922322-B1 MATERIALS FOR N-DOPING THE ELECTRON-TRANSPORTING LAYERS IN ORGANIC ELECTRONIC COMPONENTS OSRAM OPTO SEMICONDUCTORS GMBH (DE) 2012-11-28 EP disclosed
US-20090114906-A1 MATERIALS FOR N-DOPING THE ELECTRON-TRANSPORTING LAYERS IN ORGANIC ELECTRONIC COMPONENTS OSRAM OPTO SEMICONDUCTORS GMBH (DE) 2009-05-07 US disclosed
CN-101263147-A Materials for n-doping electron transport layers in organic electronic components SIEMENS AG (DE) 2008-09-10 CN disclosed
EP-1922322-A1 MATERIALS FOR N-DOPING THE ELECTRON-TRANSPORTING LAYERS IN ORGANIC ELECTRONIC COMPONENTS Siemens Aktiengesellschaft (DE) 2008-05-21 EP disclosed
WO-2007028712-A1 MATERIALS FOR N-DOPING THE ELECTRON-TRANSPORTING LAYERS IN ORGANIC ELECTRONIC COMPONENTS SIEMENS AKTIENGESELLSCHAFT (DE) 2007-03-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090114906-A1 MATERIALS FOR N-DOPING THE ELECTRON-TRANSPORTING LAYERS IN ORGANIC ELECTRONIC COMPONENTS SLCO4C1, SLC43A1, SLC43A3 CYP1A2 1221/4885CYP2A6 2824/4885APAF1 3987/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.